Israel Englander Albireo Pharma, Inc. Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$18.01 - $23.78 $2.23 Million - $2.95 Million	-123,910 Reduced 24.23%	387,567 $8.38 Million
Q3 2022 Nov 14, 2022	BUY	$16.32 - $26.37 $7.82 Million - $12.6 Million	479,023 Added 1476.01%	511,477 $9.9 Million
Q2 2022 Aug 15, 2022	SELL	$18.54 - $37.29 $526,536 - $1.06 Million	-28,400 Reduced 46.67%	32,454 $645,000
Q1 2022 May 16, 2022	SELL	$23.94 - $33.74 $3.76 Million - $5.3 Million	-157,145 Reduced 72.09%	60,854 $1.82 Million
Q4 2021 Feb 14, 2022	SELL	$21.19 - $31.29 $845,862 - $1.25 Million	-39,918 Reduced 15.48%	217,999 $5.08 Million
Q3 2021 Nov 15, 2021	BUY	$27.36 - $35.98 $721,291 - $948,540	26,363 Added 11.39%	257,917 $8.05 Million
Q2 2021 Aug 16, 2021	BUY	$28.9 - $36.87 $460,434 - $587,412	15,932 Added 7.39%	231,554 $8.15 Million
Q1 2021 May 17, 2021	SELL	$32.03 - $42.85 $1.21 Million - $1.62 Million	-37,847 Reduced 14.93%	215,622 $7.6 Million
Q4 2020 Feb 16, 2021	SELL	$31.56 - $42.16 $624,793 - $834,641	-19,797 Reduced 7.24%	253,469 $9.51 Million
Q3 2020 Nov 16, 2020	BUY	$23.19 - $41.61 $6.34 Million - $11.4 Million	273,266 New	273,266 $9.12 Million
Q4 2018 Feb 14, 2019	SELL	$20.9 - $32.57 $1.38 Million - $2.15 Million	-66,035 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$29.29 - $36.87 $1.11 Million - $1.4 Million	-37,981 Reduced 36.51%	66,035 $2.18 Million
Q2 2018 Aug 14, 2018	SELL	$28.9 - $37.31 $1.49 Million - $1.93 Million	-51,595 Reduced 33.16%	104,016 $3.69 Million
Q1 2018 May 15, 2018	BUY	$26.78 - $39.35 $2.92 Million - $4.29 Million	109,017 Added 233.97%	155,611 $5.07 Million
Q4 2017 Feb 14, 2018	BUY	$21.56 - $28.14 $397,243 - $518,479	18,425 Added 65.41%	46,594 $1.19 Million
Q3 2017 Nov 14, 2017	BUY	$20.44 - $25.65 $575,774 - $722,534	28,169	28,169 $590,000

Others Institutions Holding ALBO

# of Institutions

Shares Held

865

Call Options Held

Put Options Held

View Full List

About ALBIREO PHARMA, INC.

Ticker ALBO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,612,500
Description
Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...

More about ALBO

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account